Fused Isoxazolyl Compounds As Kat6 A Inhibitors

Abstract: The present invention provides fused isoxazolyl compound of formula (I), which are therapeutically useful as KAT6A inhibitors particularly in the treatment and/or prevention of diseases or disorders dependent upon KAT6A in a mammal. The present invention also provides preparation of the compounds and pharmaceutical compositions comprising at least one of the compound represented by formula (I) or a pharmaceutically acceptable salt or a stereoisomer or a tautomer thereof.

Patent Information

Application #

Filing Date

11 December 2023

Publication Number

01/2024

Publication Type

INA

Invention Field

CHEMICAL

Status

Email

Parent Application

Applicants

AURIGENE ONCOLOGY LIMITED

39/40(P), KIADB Industrial Area, Electronic City Phase II, Bangalore 56010

Inventors

1. VENKATESHAPPA, Chandregowda

No 709, 1st Main, 5th Cross, RHCS Layout, Srigandhakaval, Nagarabhavi Bangalore 560091

2. ABBINENI, Chandrasekhar

H. No: 15-21-48/14/G-3, Sri Sai Datta Enclave, Balaji Nagar, Kukatpally, Telangana. Hyderabad 500 072

3. SAMAJDAR, Susanta

Flat # R801, H. M Tambourine, Jaraganahalli, J.P. Nagar 6th Phase Bangalore 560 078

4. BERA, Kalisankar

B152, Block B, GM Infinite, Thirupallya road, Electronic city phase 1 Bangalore 560100

Specification

Documents

Application Documents

#	Name	Date
1	202347084395-STATEMENT OF UNDERTAKING (FORM 3) [11-12-2023(online)].pdf	2023-12-11
2	202347084395-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [11-12-2023(online)].pdf	2023-12-11
3	202347084395-FORM 1 [11-12-2023(online)].pdf	2023-12-11
4	202347084395-DECLARATION OF INVENTORSHIP (FORM 5) [11-12-2023(online)].pdf	2023-12-11
5	202347084395-COMPLETE SPECIFICATION [11-12-2023(online)].pdf	2023-12-11
6	202347084395-Proof of Right [07-02-2024(online)].pdf	2024-02-07
7	202347084395-FORM-26 [07-02-2024(online)].pdf	2024-02-07
8	202347084395-FORM 3 [10-06-2024(online)].pdf	2024-06-10